由camrelizumab诱导的眼的反应性皮肤毛细血管内皮扩散:一个病例报告
Xuecong Zhou1, Xiaoming Yan1, Yuan Wu1
1Department of Ophthalmology, Peking University First Hospital, Peking University, Beijing 100034, P.R. China.
Biomedical reports
|February 15, 2024
概括
这项案例研究突出了眼部反应性皮肤毛细血管内皮扩散 (RCCEPs) 的罕见实例,该病例发生在接受编程细胞死亡蛋白1抑制剂camrelizumab治疗的患者身上. 及时识别和管理这些与免疫相关的不良事件对于患者护理至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 免疫检查点抑制剂 (ICI),如camrelizumab,越来越多地用于癌症治疗.
- 这些疗法可以导致由于免疫系统调节而导致与免疫相关的不良事件 (irAEs).
- 反应性皮肤毛细血管内皮扩散 (RCCEPs) 是与camrelizumab相关的已知不良事件.
研究的目的:
- 报告一种罕见的眼部RCCEPs病例,该病例是由camrelizumab (SHR-1210) 诱导的.
- 强调识别irAEs异常分布的重要性.
- 讨论癌症患者免疫相关毒性的管理.
主要方法:
- 一名用camrelizumab治疗的宫癌患者的病例报告.
- 对不良事件的临床观察和记录.
- 关于RCCEP和ICI相关毒性的文献综述.
主要成果:
- 患者在治疗宫癌的卡梅利祖马布治疗后出现了眼部RCCEPs.
- 眼部呈现的RCCEPs是不常见的,典型分布在头部,子,干部和四肢.
- 患者的病情需要针对异常的病变分布进行特殊的管理.
结论:
- 眼部RCCEPs是卡姆雷利祖马布治疗的罕见但可能的不良事件.
- 及时诊断和适当的治疗,可能包括对症状性病变进行外科切除,至关重要.
- 对非典型的irAE表现的认识对于有效的癌症治疗管理至关重要.
更多相关视频
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.2K
04:48Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
287
相关概念视频
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
